105 related articles for article (PubMed ID: 30092298)
41. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
43. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
Lin L; Liu D; Liang H; Xue L; Su C; Liu M
Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
[TBL] [Abstract][Full Text] [Related]
44. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
[TBL] [Abstract][Full Text] [Related]
45. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.
Chen W; Huang L; Hao C; Zeng W; Luo X; Li X; Zhou L; Jiang S; Chen Z; He Y
Tumour Biol; 2016 Jul; 37(7):9289-99. PubMed ID: 26779627
[TBL] [Abstract][Full Text] [Related]
47. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
49. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells].
Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
Mobarra N; Shafiee A; Rad SM; Tasharrofi N; Soufi-Zomorod M; Hafizi M; Movahed M; Kouhkan F; Soleimani M
In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):604-11. PubMed ID: 25672252
[TBL] [Abstract][Full Text] [Related]
51. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
52. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
54. TIP60-miR-22 axis as a prognostic marker of breast cancer progression.
Pandey AK; Zhang Y; Zhang S; Li Y; Tucker-Kellogg G; Yang H; Jha S
Oncotarget; 2015 Dec; 6(38):41290-306. PubMed ID: 26512777
[TBL] [Abstract][Full Text] [Related]
55. Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.
Wang L; Liu C; Li C; Xue J; Zhao S; Zhan P; Lin Y; Zhang P; Jiang A; Chen W
Gene; 2015 Nov; 572(2):252-8. PubMed ID: 26164758
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
59. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation.
Antalis CJ; Arnold T; Rasool T; Lee B; Buhman KK; Siddiqui RA
Breast Cancer Res Treat; 2010 Aug; 122(3):661-70. PubMed ID: 19851860
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]